PharmaCorp RxTSXV:PCRX +16.00%35 Days Inventory is 59.76 as of Mar. 2026, which is 37% below its 10-year median of 95.47. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 493 Healthcare Providers & Services companies, PharmaCorp Rx ranks worse than 69.98% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). PharmaCorp Rx's Average Total Inventories for the
three
months ended in Mar. 2026 was C$2.88 Mil. PharmaCorp Rx's Cost of Goods Sold for the
three
months ended in Mar. 2026 was C$4.40 Mil.
Hence, PharmaCorp Rx's Days Inventory for the
three
months ended in Mar. 2026 was 59.76.
The historical rank and industry rank for PharmaCorp Rx's Days Inventory or its related term are showing as below:
TSXV:PCRX'
s Days Inventory Range Over the Past 10 Years
Min: 57.65 Med: 95.47 Max: 132.72
Current: 57.65
During the past 5 years, PharmaCorp Rx's highest Days Inventory was 132.72. The lowest was 57.65. And the median was 95.47.
TSXV:PCRX's Days Inventory is ranked worse than 69.98% of 493
companies
in the Healthcare Providers & Services industry
Industry Median: 30.04
vs TSXV:PCRX: 57.65
PharmaCorp Rx's Days Inventory
increased
from Mar. 2025 (56.19) to Mar. 2026 (59.76).
It might indicate that PharmaCorp Rx's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PharmaCorp Rx's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.53.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PharmaCorp Rx's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.40.
PharmaCorp Rx (TSXV:PCRX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PharmaCorp Rx's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PharmaCorp Rx's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PharmaCorp Rx Days Inventory Related Terms
PharmaCorp Rx Days Inventory Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaCorp Rx Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's Days Inventory distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaCorp Rx (TSXV:PCRX) has a Days Inventory of 59.76 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PharmaCorp Rx and its competitors. This is 37% below median its historical median of 95.47. Over the past decade, PharmaCorp Rx's Days Inventory has ranged from 57.65 to 132.72. According to the industry distribution chart, PharmaCorp Rx ranks #345 out of 493 companies in the Healthcare Providers & Services industry, placing it in the top 70%.
Is PharmaCorp Rx's Days Inventory too high?
PharmaCorp Rx's current Days Inventory of 59.76 is 37% below median its 10-year median of 95.47. Over the past 10 years, this metric has ranged from a low of 57.65 to a high of 132.72. The Healthcare Providers & Services industry median Days Inventory is 30.04. PharmaCorp Rx's value of 59.76 is 98.9% above this industry median. Based on the distribution chart, PharmaCorp Rx ranks #345 out of 493 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #345 out of 493 companies for Days Inventory. This places PharmaCorp Rx in the lower half of its industry. The industry median Days Inventory is 30.04. PharmaCorp Rx's value of 59.76 is 98.9% above this benchmark. Historically, PharmaCorp Rx's own Days Inventory has ranged from 57.65 to 132.72 over the past decade. While the company's 10-year median is 95.47 vs. the industry median of 30.04, PharmaCorp Rx has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.04, based on 493 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaCorp Rx's current Days Inventory of 59.76 is 98.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PharmaCorp Rx and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCorp Rx's current Days Inventory is 59.76, which is 37% below median its own 10-year median of 95.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Days Inventory of 59.76. The current Days Inventory is 59.76, which is 37% below median its 10-year median of 95.47 and 98.9% above the Healthcare Providers & Services industry median of 30.04. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Days Inventory is 59.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score
Get the complete analysis for TSXV:PCRX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
